Humira and Exostosis - a phase IV clinical study of FDA data
Summary:
We study 647,817 people who have side effects when taking Humira. Exostosis is found, especially among people who are female, 50-59 old, have been taking the drug for 2 - 5 years, also take Enbrel and have Pain.
The phase IV clinical study analyzes which people take Humira and have Exostosis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
647,817 people reported to have side effects when taking Humira.
Among them, 1,868 people (0.29%) have Exostosis.
What is Humira?
Humira has active ingredients of adalimumab. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 738,352 Humira users.
What is Exostosis?
Exostosis (formation of new bone on the surface of a bone) is found to be associated with 1,694 drugs and 924 conditions by eHealthMe. Currently, we are studying 12,965 people who have Exostosis.
Number of Humira and Exostosis reports submitted per year:

Time on Humira when people have Exostosis *:
Gender of people who have Exostosis when taking Humira*:
Age of people who have Exostosis when taking Humira *:
Common drugs people take besides Humira *:
Common side effects people have besides Exostosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Humira and have Exostosis?
Check whether Exostosis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Related studies
How severe was Exostosis and when was it recovered:
Expand to all the drugs that have ingredients of adalimumab:
- Exostosis and drugs with ingredients of adalimumab (1,389 reports)
Alternative drugs to, pros and cons of Humira:
- Humira (738,352 reports)
Browse all side effects of Humira:
a b c d e f g h i j k l m n o p q r s t u v w x y zExostosis treatments and more:
- Exostosis (12,965 reports)
Common drugs associated with Exostosis:
- Fosamax: 2,383 reports
- Humira: 1,868 reports
- Zometa: 1,330 reports
- Methotrexate: 1,313 reports
- Prednisone: 1,307 reports
- Enbrel: 1,141 reports
- Aspirin: 959 reports
- Aredia: 807 reports
- Celebrex: 745 reports
- Gabapentin: 694 reports
All the drugs that are associated with Exostosis:
- Exostosis (1,694 drugs)
Common conditions associated with Exostosis:
- Rheumatoid arthritis: 2,387 reports
- Osteoporosis: 2,190 reports
- Pain: 931 reports
- High blood pressure: 870 reports
All the conditions that are associated with Exostosis:
- Exostosis (924 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diazepam and Rash Maculo-Papular - now
- Talwin and Cyclophosphamide drug interaction - 2 seconds ago
- Eliquis and Marlissa drug interaction - 2 seconds ago
- Tramadol and Optic Neuropathy - 14 seconds ago
- Fluconazole and Retinal Toxicity - 18 seconds ago
- Hydroxychloroquine Sulfate and Tremor - 20 seconds ago
- Accuretic and Miralax drug interaction - 24 seconds ago
- Entresto and Naproxen drug interaction - 28 seconds ago
- Proventil and Yasmin drug interaction - 54 seconds ago
- Fenofibrate and Xtandi drug interaction - 56 seconds ago